Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model

Intravesical bacillus Calmette-Guerin (BCG) treatment is the most common therapy to prevent progression and recurrence of non-muscle invasive bladder cancer (NMIBC). Although the immunoreaction elicited by BCG treatment is well documented, those induced by intravesical treatment with chemotherapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hori, Shunta, Miyake, Makito, Tatsumi, Yoshihiro, Onishi, Sayuri, Morizawa, Yosuke, Nakai, Yasushi, Tanaka, Nobumichi, Fujimoto, Kiyohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391151/
https://www.ncbi.nlm.nih.gov/pubmed/28406993
http://dx.doi.org/10.1371/journal.pone.0175494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391151/
https://www.ncbi.nlm.nih.gov/pubmed/28406993
http://dx.doi.org/10.1371/journal.pone.0175494

Ejemplares similares